Gain Therapeutics Company

Gain Therapeutics is a biotech company developing pharmacological chaperones drugs designed to treat rare metabolic disorders.

Headquarters: Bethesda, Maryland, United States
Total Funding: 14396508.0
Founded Date: 2017-01-01
Last Funding Type: Series B
Investors Number: 6.0
Last Funding Date: 2020-07-21
Funding Status: IPO
Estimated Revenue: Less than $1M
Industry: Preclinical Development